Zhen-Zhen Wang

Zhen-Zhen Wang

Auto-generated profile, based on publicly available information

Zhen-Zhen Wang

Henan University of Chinese Medicine, Zhengzhou, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2022 in RSC Advances
Verified
Journal Article
Open access
PDF file
ZWZhen-Zhen Wang
Zhen-Zhen Wang
YJYuan Jia
Yuan Jia
GWGuoqiang Wang
Guoqiang Wang
HHHongjuan He
Hongjuan He
LCLihua Cao
Lihua Cao
XLXiu-min Li
Xiu-min Li
We discovered a dynamic covalent hydrogel with 3D pore structure, in which baicalin were linked by boronate esters. The baicalin hydrogel displayed remarkable thixotropy, moldability, self-healing, and multi-stimuli-responsive properties.

12 August 2025 in IMA Fungus
Verified
Journal Article
Open access
PDF file
ZZZhen-Zhu Zhao
Zhen-Zhu Zhao
YWYan Wang
Yan Wang
XWXiao-Yu Wang
Xiao-Yu Wang
HCHui Chen
Hui Chen
ZWZhen-Zhen Wang
Zhen-Zhen Wang
Wei-Sheng FengWei-Sheng Feng
Wei-Sheng Feng
The genus Xylaria is a promising source of bioactive compounds. This study examined the diversity of secondary metabolites (SMs) in Xylaria longipes under three fermentation conditions, resulting in the isolation of 14 new SMs and 27 known ones. The structures, including absolute configurations, were determined using NMR spectroscopy, HRESIMS analysis, and computational methods (ECD, ¹³C NMR data, and optical rotation). A comprehensive library of SMs was established, enabling metabolomics-wide association studies that identified culture conditions as a key factor influencing SM production. This compound library also facilitates the determination of absolute configurations for diplosporins by analyzing J values and CD trends. Anti-proliferative tests against induced T/B lymphocytes and HaCaT cells revealed that over half of the compounds exhibited significant inhibitory activity, with compounds 2, 15, and 32 reducing IFN-γ secretion. Compound 32 demonstrated promising anti-psoriatic effects by inhibiting NF-κB p65 phosphorylation in HaCaT cells. This initial systematic chemical study of X. longipes under different conditions provides insights into structure–activity relationships.

15 March 2022 in Journal of Healthcare Engineering
Verified
Journal Article
Open access
PDF file
LCLihua Cao
Lihua Cao
XJXing-Yuan Jia
Xing-Yuan Jia
HHHong-Juan He
Hong-Juan He
ZWZhen-Zhen Wang
Zhen-Zhen Wang
YZYi-Ying Zhao
Yi-Ying Zhao
MMMingsan Miao
Mingsan Miao
The first reported case of coronavirus disease 2019 (COVID-19) occurred in Wuhan, Hubei, China. Thereafter, it spread through China and worldwide in only a few months, reaching a pandemic level. It can cause severe respiratory illnesses such as pneumonia and lung failure. Since the onset of the disease, the rapid response and intervention of traditional Chinese medicine (TCM) have played a significant role in the effective control of the epidemic. Yinqiaosan (YQS) was used to treat COVID-19 pneumonia, with good curative effects. However, a systematic overview of its active compounds and the therapeutic mechanisms underlying its action has yet to be performed. The purpose of the current study is to explore the compounds and mechanism of YQS in treating COVID-19 pneumonia using system pharmacology. A system pharmacology method involving drug-likeness assessment, oral bioavailability forecasting, virtual docking, and network analysis was applied to estimate the active compounds, hub targets, and key pathways of YQS in the treatment of COVID-19 pneumonia. With this method, 117 active compounds were successfully identified in YQS, and 77 potential targets were obtained from the targets of 95 compounds and COVID-19 pneumonia. The results show that YQS may act in treating COVID-19 pneumonia and its complications (atherosclerosis and nephropathy) through Kaposi sarcoma-related herpesvirus infection and the AGE-RAGE signaling pathway in diabetic complications and pathways in cancer. We distinguished the hub molecular targets within pathways such as TNF, GAPDH, MAPK3, MAPK1, EGFR, CASP3, MAPK8, mTOR, IL-2, and MAPK14. Five of the more highly active compounds (acacetin, kaempferol, luteolin, naringenin, and quercetin) have anti-inflammatory and antioxidative properties. In summary, by introducing a systematic network pharmacology method, our research perfectly forecasts the active compounds, potential targets, and key pathways of YQS applied to COVID-19 and helps to comprehensively clarify its mechanism of action.

13 May 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
ZWZhen-Zhen Wang
Zhen-Zhen Wang
YJYuan Jia
Yuan Jia
KSKamal D. Srivastava
Kamal D. Srivastava
WHWeihua Huang
Weihua Huang
Raj K. TiwariRaj K. Tiwari
Raj K. Tiwari
XLXiu-min Li
Xiu-min Li
Eczema is a complex chronic inflammatory skin disease impacted by environmental factors, infections, immune disorders, and deficiencies in skin barrier function. Shi Zhen Tea (SZT), derived from traditional Chinese medicine Xiao-Feng-San, has shown to be an effective integrative therapy for treating skin lesions, itching, and sleeping loss, and it facilitates reduction of topical steroid and antihistamine use in pediatric and adult patients with severe eczema. Yet, its active compounds and therapeutic mechanisms have not been elucidated. In this study, we sought to investigate the active compounds and molecular mechanisms of SZT in treating eczema using systems pharmacology and in silico docking analysis. SZT is composed of 4 medicinal herbs, Baizhu (Atractylodis macrocephalae rhizome), Jingjie (Schizonepetae herba), Kushen (Sophorae flavescentis radix), and Niubangzi (Arctii fructus). We first identified 51 active compounds from SZT and their 81 potential molecular targets by high-throughput computational analysis, from which we identified 4 major pathways including Th17 cell differentiation, metabolic pathways, pathways in cancer, and the PI3K-Akt signaling pathway. Through network analysis of the compound-target pathway, we identified hub molecular targets within these pathways including carbonic anhydrase II (CA2), peroxisome proliferator activated receptor γ (PPAR γ), retinoid X receptor α (RXRA), and vitamin D receptor (VDR). We further identified top 5 compounds including cynarine, stigmasterin, kushenol, β-sitosterol, and (24S)-24-propylcholesta-5-ene-3β-ol as putative key active compounds on the basis of their molecular docking scores with identified hub target proteins. Our study provides an insight into the therapeutic mechanism underlying multiscale benefits of SZT for eczema and paves the way for developing new and potentially more effective eczema therapies.

7 June 2021 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
ZSZhimin Sun
Zhimin Sun
ZWZhenzhen Wang
Zhenzhen Wang
YNYanhai Ni
Yanhai Ni
LXLihui Xi
Lihui Xi
LRLoïc M. Roch
Loïc M. Roch
MOMark Anthony Olson
Mark Anthony Olson
Atmospheric water adsorbed hygroscopically with changes in relative humidity mediates competing n → π* and π → π* donor–acceptor charge transfer interactions leading to unexpected three-state hydrochromic switching in the solid state.

18 August 2026 in Materials Today Bio
Verified
Journal Article
Open access
ZWZhen-Zhen Wang
Zhen-Zhen Wang
LCLihua Cao
Lihua Cao
ZZZhenzhu Zhao
Zhenzhu Zhao
MZMengke Zhao
Mengke Zhao
YLYanyan Lu
Yanyan Lu
XSXiaobo Sun
Xiaobo Sun
TLR4 activation and the cascade of neutrophil extracellular trap (NET) formation exacerbate excessive inflammation and organ damage in the pathogenesis of acute lung injury (ALI), yet effective pharmacological interventions remain unavailable. Nanoaggregates derived from natural products offer promising avenue by leveraging synergistic anti-inflammatory effects. In this study, we surprisingly discovered that leonurine and ursolic acid spontaneously self-assemble into nanoparticles (LUNP) through non-covalent interactions, achieving a drug loading capacity of 100%. The LUNP platform exhibits superior biophysical properties, including enhanced mucus penetration, pH-responsive drug release, improved cellular uptake, and prolonged retention within inflamed lung tissue. Mechanistically, LUNP ameliorates ALI by dampening TLR4/MyD88/NF-κB-driven inflammatory activation, thereby remodeling the microenvironment to limit NOX4-PAD4-mediated NET formation. Notably, inhalational LUNP exhibits outstanding biosafety with minimal off-target distribution. Overall, this work introduces a synergistic self-assembled nanoplatform for precise pulmonary intervention in ALI, showcasing its ability to safely and effectively orchestrate the coordinated modulation of multiple pathological pathways. In summary, by inhibiting both TLR4 activation and NET formation, the synergistic LUNP platform offers an efficient, safe, and easily accessible therapeutic strategy for ALI, providing a promising solution for clinical translation.